BXPHARMA: Beximco Pharma
Beximco Pharmaceuticals Ltd (BPL) is a leading manufacturer of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) in Bangladesh. The company is one …
EU vs US Market Access for Bangladesh
The revised Rules of Origin (RoO) adopted by the European Commission, effective since 1 January 2011, allows Bangladesh to continue enjoying EU’s …
The Bangladesh Paradox
The Bangladesh Paradox: Bangladesh has achieved strong growth since the early 1990s. The World Bank estimates that it could join the ranks of …
Bangladesh’s exports
Bangladesh’s exports achieved a growth rate of 4.8% for the FY10 (year-to-year). The positive trend continued in the first two months of …
Investments and Policy Reforms in Bangladesh
Investment has been one of the major constraints to faster growth in FY10. Gross domestic investment remained stagnant at 24.4% of GDP …
Is Bangladesh the Next CHINDIA
In spite of typical challenges of a developing country Bangladesh has proven to be one of the consistently growing economies in the …
Ministerialrat vom Bundeswirtschaftsministerium diskutiert bilateralen Handel und Investitionen mit Bangladesch
Bis vor kurzem bekam Bangladesch wenig Aufmerksamkeit aus Deutschland hinsichtlich des Handels und Investitionen. Das steigende bilaterale Handelsvolumen und die jüngsten Besuche …
German economic ministry high official discusses bilateral trade and investment with Bangladesh
Until recently Bangladesh could not draw much German attention for trade and investment. Increasing bilateral trade volume and recent high-profile official visits from …
Keine Extrakosten für die Ausstellung der EU GSP Form A
Seit 1. Januar 2011 hat die EU eine neue Regelung für die Ausstellung eines „preferential certificate of origin GSP form A” für …
NO extra costs applicable for issuance of EU GSP form A
As of 1st January 2011 a preferential certificate of origin GSP form A may be issued for imported primary materials in a …